Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advair Dose Response on eNO in Asthma
NCT00927758Phase 2Completed
- Sponsor
- Sandoz
- Start
- Jun 2009
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of fluticasone propionate in asthma (6 arms), sponsored by Sandoz. Primary endpoint: Percentage Change From Baseline in Exhaled Nitric Oxide (eNO) at 7 days. Started Jun 2009; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00927758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927758.